Johnson & Johnson outlines double-digit growth ambition by end of decade as 2026 sales set to surpass $100B (NYSE:JNJ)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...